Samalin Investment Counsel, LLC Gsk PLC Transaction History

Samalin Investment Counsel, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $139,984 - $159,026	-3,329 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $482 - $572	-12 Reduced 0.36%	3,329 $145 Million
Q4 2021 Feb 15, 2022	BUY	$38.88 - $45.31 $24,027 - $28,001	618 Added 22.7%	3,341 $147 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $1,047 - $1,165	27 Added 1.0%	2,723 $104 Million
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $98,457 - $111,776	2,696 New	2,696 $109,000
Q1 2021 May 11, 2021	SELL	$34.27 - $40.01 $90,301 - $105,426	-2,635 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$34.07 - $39.94 $22,486 - $26,360	-660 Reduced 20.03%	2,635 $97 Million
Q3 2020 Nov 10, 2020	BUY	$38.11 - $42.99 $125,572 - $141,652	3,295 New	3,295 $126,000
Q1 2020 May 04, 2020	SELL	$32.47 - $48.83 $119,911 - $180,329	-3,693 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$42.0 - $48.25 $155,106 - $178,187	3,693 New	3,693 $173,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.